Advertisement
Screener

ASTRAZENECA PLC (AZN) Form 6-K: Report of foreign private issuer, 2013

2.4 / 5 stars · 19/40 Roast Me

Add as a preferred source on Google

ASTRAZENECA PLC Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2013-12-27: Form 6-K; Period of report 2013-12-27; Description AZ AND SHIONOGI EXTEND CRESTOR AGREEMENT; Document azn201312276k.htm.
  • 2013-12-19: Form 6-K; Period of report 2013-12-19; Description DIRECTOR/PDMR SHAREHOLDING; Document azn201312196k1.htm.
  • 2013-12-19: Form 6-K; Period of report 2013-12-19; Description AZ TO ACQUIRE BMS SHARE OF DIABETES ASSETS; Document azn201312196k.htm.
  • 2013-12-17: Form 6-K; Period of report 2013-12-17; Description STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US; Document azn201312176k.htm.
FiledFormPeriod of reportDescriptionDocument
2013-12-276-K2013-12-27AZ AND SHIONOGI EXTEND CRESTOR AGREEMENTazn201312276k.htm
2013-12-196-K2013-12-19DIRECTOR/PDMR SHAREHOLDINGazn201312196k1.htm
2013-12-196-K2013-12-19AZ TO ACQUIRE BMS SHARE OF DIABETES ASSETSazn201312196k.htm
2013-12-176-K2013-12-17STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN USazn201312176k.htm
2013-12-136-K2013-12-13FDA ADVISORY COMMITTEE RECOMMENDS DAPAGLIFLOZINazn201312136k.htm
2013-12-136-K2013-12-13TOP LINE RESULTS FROM PHASE III STUDY OF LESINURADazn201312136k1.htm
2013-12-126-K2013-12-12FDA ADVISORY COMMITTEE VOTES ON METRELEPTINazn201312126k.htm
2013-12-066-K2013-12-06EUROPEAN COMMISSION APPROVES FLUENZ TETRAazn201312066k.htm
2013-12-026-K2013-12-02BLOCKLISTING INTERIM REVIEWazn201312026k1.htm
2013-12-026-K2013-12-02TOTAL VOTING RIGHTSazn201312026k.htm
2013-11-226-K2013-11-22XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETESazn201311226k.htm
2013-11-196-K2013-11-19NDA FOR NALOXEGOL ACCEPTED BY US FDAazn201311196k.htm
2013-11-016-K2013-11-01TOTAL VOTING RIGHTSazn201311016k1.htm
2013-11-016-K2013-11-01DIRECTOR/PDMR SHAREHOLDINGazn201311016k.htm
2013-10-316-K/A2013-10-31MARC DUNOYER APPOINTED CHIEF FINANCIAL OFFICERazn201310316ka.htm
2013-10-316-K2013-10-31US COURT DECISION IN PULMICORT RESPULES LITIGATIONazn201310316k4.htm
2013-10-316-K2013-10-31MARC DUNOYER APPOINTED CHIEF FINANCIAL OFFICERazn201310316k2.htm
2013-10-316-K2013-10-313RD QUARTER RESULTSazn201310316k.htm
2013-10-306-K2013-10-30NOTICE OF RESULTSazn201310306k.htm
2013-10-306-K2013-10-30ASTRAZENECA ADVANCES BENRALIZUMAB TO PHASE IIIazn201310306k1.htm
2013-10-226-K2013-10-22ASTRAZENECA STARTS PHASE III STUDY FOR SELUMETINIBazn201310226k.htm
2013-10-156-K2013-10-15MEDIMMUNE ACQUIRES SPIROGENazn201310156k.htm
2013-10-076-K2013-10-07MEDIMMUNE COMPLETES AMPLIMMUNE ACQUISITIONazn201310076k.htm
2013-10-016-K2013-10-01TOTAL VOTING RIGHTSazn201310016k.htm
2013-09-306-K2013-09-30MAA FOR OLAPARIB ACCEPTED BY EMAazn201309306k.htm
2013-09-276-K2013-09-27MAA APPLICATION FOR NALOXEGOL ACCEPTEDazn201309276k.htm
2013-09-206-K2013-09-20FLUENZ TETRA RECEIVES POSITIVE CHMP OPINION IN EUazn201309206k.htm
2013-09-046-K2013-09-04STARTS PHASE III CLINICAL PROGRAMME FOR OLAPARIBazn201309046k.htm
2013-09-036-K2013-09-03TOTAL VOTING RIGHTSazn201309026k.htm
2013-08-276-K2013-08-27MEDIMMUNE ACQUIRES AMPLIMMUNEazn201308276k.htm
2013-08-016-K2013-08-01TOTAL VOTING RIGHTSazn201308016k3.htm
2013-08-016-K2013-08-01DIRECTOR/PDMR SHAREHOLDINGazn201308016k2.htm
2013-08-016-K2013-08-01HALF YEARLY PIPELINE UPDATEazn201308016k1.htm
2013-08-016-K2013-08-01HALF YEARLY REPORTazn201308016k.htm
2013-07-316-K2013-07-31NOTICE OF RESULTSazn201307306k.htm
2013-07-316-K2013-07-31COLLABORATES WITH FIBROGEN ON ANAEMIA TREATMENTazn201307316k.htm
2013-07-266-K2013-07-26FDA RECEIPT OF DAPAGLIFLOZIN RESUBMISSIONazn201307266k.htm
2013-07-256-K2013-07-25ASTRAZENECA COMPLETES ACQUISITION OF OMTHERAazn201307196k.htm
2013-07-156-K2013-07-15SIMON LOWTH, CFO, TO LEAVE ASTRAZENECAazn201307156k.htm
2013-07-116-K2013-07-11HOLDING(S) IN COMPANYazn201307116k.htm
2013-07-016-K2013-07-01TOTAL VOTING RIGHTSazn201307016k.htm
2013-06-286-K2013-06-28PUBLICATION OF PROSPECTUSazn201306286k1.htm
2013-06-286-K2013-06-28COMPLETES ACQUISITION OF PEARL THERAPEUTICSazn201306286k.htm
2013-06-196-K2013-06-19ANNOUNCES TOP-LINE RESULTS FOR SAVOR STUDYazn201306196k.htm
2013-06-126-K2013-06-12DIRECTOR/PDMR SHAREHOLDINGazn201306126k.htm
2013-06-126-K2013-06-12DIRECTOR/PDMR SHAREHOLDINGazn201306126k1.htm
2013-06-126-K2013-06-12DIRECTOR/PDMR SHAREHOLDINGazn201306126k2.htm
2013-06-126-K2013-06-12TO ACQUIRE PEARL THERAPEUTICSazn201306116k.htm
2013-06-046-K2013-06-04TOP-LINE RESULTS FROM PHASE III OSKIRA TRIALSazn201306046k.htm
2013-06-036-K2013-06-03BLOCKLISTING INTERIM REVIEWazn201306036k1.htm
2013-06-036-K2013-06-03TOTAL VOTING RIGHTSazn201306036k.htm
2013-05-286-K2013-05-28APPEAL AGAINST GENERIC PULMICORT RESPULESazn201305286k.htm
2013-05-286-K2013-05-28ACQUIRES OMTHERA PHARMACEUTICALSazn201305286k1.htm
2013-05-146-K2013-05-08DIRECTOR/PDMR SHAREHOLDINGazn201305146k.htm
2013-05-086-K2013-05-08DIRECTOR/PDMR SHAREHOLDINGazn201305086k1.htm
2013-05-086-K2013-05-08DIRECTOR/PDMR SHAREHOLDINGazn201305086k.htm
2013-05-026-K2013-05-02DIRECTOR/PDMR SHAREHOLDINGazn201305026k.htm
2013-05-016-K2013-05-01DIRECTOR/PDMR SHAREHOLDINGazn201305016k2.htm
2013-05-016-K2013-05-01TOTAL VOTING RIGHTSazn201305016k.htm
2013-04-296-K2013-04-29DIRECTOR/PDMR SHAREHOLDINGazn201304296k1.htm
2013-04-296-K2013-04-29DIRECTOR/PDMR SHAREHOLDINGazn201304296k.htm
2013-04-256-K2013-04-25RESULT OF AGMazn201304256k1.htm
2013-04-256-K2013-04-251ST QUARTER RESULTSazn201304256k.htm
2013-04-246-K2013-04-23NOTICE OF RESULTSazn201304236k.htm
2013-04-056-K2013-04-05TOP-LINE RESULTS FROM OSKIRA-1 PHASE III STUDYazn201304056k.htm
2013-04-036-K2013-04-03DIRECTOR/PDMR SHAREHOLDINGazn201304036k.htm
2013-04-036-K2013-04-03DIRECTOR/PDMR SHAREHOLDINGazn201304036k1.htm
2013-04-026-K2013-04-02TOTAL VOTING RIGHTSazn201304026k2.htm
2013-04-026-K2013-04-02DIRECTOR/PDMR SHAREHOLDINGazn201304026k1.htm
2013-04-026-K2013-04-02US COURT SAYS ONE PULMICORT PATENT INVALIDazn201304026k.htm
2013-03-276-K2013-03-27DIRECTOR/PDMR SHAREHOLDINGazn201303276k.htm
2013-03-276-K2013-03-27DIRECTOR/PDMR SHAREHOLDINGazn201303276k1.htm
2013-03-266-K2013-03-26DIRECTOR/PDMR SHAREHOLDINGazn201303266k1.htm
2013-03-266-K2013-03-26FILING OF ANNUAL REPORT ON FORM 20-F WITH SECazn201303266k.htm
2013-03-266-K2013-03-26FORM 6-Kdp37095_6k.htm
2013-03-256-K2013-03-25ANNUAL FINANCIAL REPORTazn201303226k.htm
2013-03-256-K2013-03-25ASTRAZENECA SETTLES OVER CRESTOR PATENTazn201303256k.htm
2013-03-216-K2013-03-20ASTRAZENECA OUTLINES GROWTH STRATEGYazn201303216k2.htm
2013-03-216-K2013-03-20ASTRAZENECA PARTNERS KAROLINSKA INSTITUTEazn201303216k1.htm
2013-03-216-K2013-03-20ASTRAZENECA ANNOUNCES AGREEMENT WITH MODERNAazn201303216k.htm
2013-03-186-K2013-03-18ASTRAZENECA TO ESTABLISH STRATEGIC R&D CENTRESazn201303186k.htm
2013-03-146-K2013-03-14BLOCK LISTING APPLICATIONazn201303146k.htm
2013-03-056-K2013-03-05AUSTRALIAN COURT HOLDS CRESTOR PATENTS INVALIDazn201303056k.htm
2013-03-016-K2013-03-01TOTAL VOTING RIGHTSazn201303016k.htm
2013-02-276-K2013-02-27DIRECTOR/PDMR SHAREHOLDINGazn201302276k2.htm
2013-02-276-K2013-02-27DIRECTOR/PDMR SHAREHOLDINGazn201302276k1.htm
2013-02-276-K2013-02-27DIRECTOR/PDMR SHAREHOLDINGazn201302276k3.htm
2013-02-276-K2013-02-27DIRECTOR/PDMR SHAREHOLDINGazn201302276k.htm
2013-02-016-K2013-02-01TOTAL VOTING RIGHTSazn201302016k.htm
2013-01-316-K2013-01-31FINAL RESULTSazn201301316k.htm
2013-01-306-K2013-01-29NOTICE OF RESULTSazn201301296k.htm
2013-01-156-K2013-01-15ANNOUNCES CHANGES TO SENIOR EXECUTIVE TEAMazn201301156k.htm
2013-01-026-K2013-01-02TOTAL VOTING RIGHTSazn201301026k1.htm
2013-01-026-K2013-01-02DIRECTOR/PDMR SHAREHOLDINGazn201301026k.htm
Advertisement